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 Th e costs of progressive chronic kidney 
disease (CKD) in terms of patient mor-
bidity, mortality, and, of course, its eco-
nomic burden have been discussed 
repeatedly. On one point there is unanim-
ity, namely, that the frequency of CKD 
continues to grow. For example, on the 
basis of indices of health collected from 
nationally representative samples of adults 
in the United States during the 1999 – 2004 
National Health and Nutrition Examina-
tion Survey (NHANES), it was concluded 
that the prevalence of stages 1 – 4 CKD was 
as high as 13 % ! 1 Such data have under-
standably sparked interest in identifying 
mechanisms that cause the progressive 
loss of kidney function (that is, progres-
sion) and in devising treatments to pre-
vent progression. Th ere have been at least 
partial successes: pharmacologic inhibi-
tion of the renin – angiotensin – aldosterone 
system was shown to improve the out-
come of CKD in rodents and can slow 
progression in patients with different 
types of CKD. 2 On the basis of the estab-
lished benefi ts of protein-restricted diets 
in improving the mortality and renal 
pathology that occur in rodent models of 
CKD, 3 the influence of dietary protein 
restriction on progression has also been 
studied. Th is strategy slowed progression in 
rodent models of CKD and exhibited mixed 
outcomes with regard to slowing progres-
sion in nondiabetic CKD patients. 4,5 
 Gao and colleagues 6 (this issue) describe 
their results detailing how dietary mani-
pulation can initiate an unexpected mech-
anism that suppresses the pathologic 
changes that occur in the kidneys of a rat 
model of CKD (subtotal nephrectomy). 
Th eir treatment was directed at addressing 
two questions: Would ketoacids infl uence 
the course of CKD beyond what can be 
attributed to the supplying of a nitrogen-
free supplement of essential amino acids? 
Secondly, why is renal interstitial fi brosis 
prominent in CKD? Th e fi rst question was 
raised because there is evidence in humans 
that the ketoacid of leucine, namely   -
ketoisocaproate, improves protein metab-
olism to a greater degree than leucine does, 
a response that occurs even when   -ketoi-
socaproate is administered without other 
ketoacids or amino acids. 7 Th eir attempts 
to address the second question involved 
assessment of changes in the renal expres-
sion of the transcription factor Kruppel-
like factor-15 (KLF15) and how it aff ected 
the development of CKD-stimulated 
fi brosis in the kidney. Th e latter experi-
ments were undertaken because the rapid-
ity of progression is generally related to 
the degree of interstitial infl ammation and 
fibrosis, and, in the heart, KLF15 can 
reduce the transcription of connective tis-
sue growth factor. KLF15 abundance was 
reduced in the remnant kidneys of CKD 
rats fed normal chow containing 22 % pro-
tein. In the next stage, the authors exam-
ined whether dietary protein restriction 
and ketoacids would reduce fi brosis in the 
remnant kidney. Th e experimental plan 
was straightforward and was based on 
assessments of diff erences in histologic 
damage and indices of kidney function in 
CKD rats fed the 22 % protein diet versus 
CKD rats fed 6 % protein (low-protein diet 
(LPD)) or 5 % protein and 1 % ketoacids 
(LPD-KA). Th e results confi rmed that the 
LPD reduced both proteinuria and the 
increase in blood urea nitrogen; the 
authors also found a reduced degree of 
macrophage infi ltration and tubulointersti-
tial lesions, including interstitial fi brosis. 4 
In addition, mRNA levels of infl ammatory 
genes in kidneys of CKD rats were lower 
in rats fed the LPD. All these benefi cial 
responses were improved further in rats 
fed the ketoacid-supplemented diet. A 
novel result was the increase in the expres-
sion of KLF15 (mRNA and protein) in 
kidneys of CKD rats fed the LPD or the 
LPD-KA diet as compared with the nor-
mal protein chow. Notably, this increase 
in KLF15 expression in remnant kidneys 
was associated with improvements in both 
pathologic changes in the kidney and 
decreased expression of type IV collagen 
and fibronectin. Other experimental 
results included a demonstration that the 
LPD raised renal levels of KLF15 mRNA 
in mesangial cells, while KLF15 knockout 
mice exhibited heightened susceptibility to 
injury. These responses support the 
authors ’ conclusions that KLF15 is involved 
in the pathogenesis of renal interstitial 
fi brosis in CKD ( Figure 1 ). 
 Th ese fi ndings are provocative, and, like 
many impressive results obtained in stud-
ies of animal models, they prompt more 
investigations to address several ques-
tions. First, do the results translate into an 
improvement or stabilization of kidney 
function? Th is question was not formally 
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addressed, but the available evidence sug-
gests that the LPD or the LPD-KA diet did 
not improve renal function, as the serum 
creatinine values were not statistically dif-
ferent. Second, what is the mechanism 
that underlies the reduction in interstitial 
damage associated with dietary protein 
restriction? Intriguing possibilities include 
inhibition of responses to metabolic aci-
dosis and / or improvement of defects 
in insulin – insulin-like growth factor-1 
cellular signaling that are due to renal 
insufficiency. Regarding acidosis, the 
metabolism of sulfa-containing amino 
acids in dietary protein and the degree of 
renal insuffi  ciency are the major determi-
nants of the degree of acidosis in CKD. In 
the study by Gao  et al. , 6 there was an 
increase in bicarbonate stores in CKD rats 
fed the LPD or the LPD-KA diet as com-
pared with the 22 % protein diet. This 
would counteract the infl uence of acidosis 
and explain why the authors found essen-
tially normal values of serum bicarbonate 
in CKD rats fed the protein-restricted 
diets. Th is result is relevant because cor-
rection of acidosis could improve renal 
function. For example, results from a 
recent clinical trial testing responses to an 
oral supplement of sodium bicarbonate 
revealed that the therapy slowed the loss 
of kidney function. 8 Th e suggestion that 
there is a role for defects in intracellular 
signaling as a mechanism linking KLF15 
to renal fi brosis arises from the observa-
tion that KLF15 has been identifi ed as a 
regulator of gluconeogenesis and adi-
pocyte diff erentiation. Not only is it estab-
lished that CKD interferes with the 
insulin – insulin-like growth factor-1 sig-
naling pathway, but we also recently found 
that impaired insulin-like growth factor-1 
signaling can stimulate the development 
of fibrosis in muscle, especially when 
CKD is present. 9 Th us, it is tempting to 
speculate that the dietary manipulation 
used by Gao  et al. 6 might reduce the 
development of fi brosis in other organs as 
well as in the kidney. Third, activated 
fi broblasts contribute to the excessive pro-
duction of extracellular matrix. However, 
the origin of these fibroblasts remains 
controversial. We recently found (our 
unpublished results) that bone marrow-
derived fibroblasts contribute to the 
pathogenesis of fi brosis in the kidney. As 
Gao  et al. 6 found that the LPD or LPD-KA 
diet reduces the degree of macrophage 
infiltration in the kidney, it would be 
interesting to determine whether these 
diets also inhibit  infiltration of bone 
marrow-derived fi broblasts. 
 Fortunately, long-term experience with 
ketoacid-supplemented, low-protein diets 
indicates they are safe and effective in 
ameliorating metabolic complications of 
CKD, making this type of therapy at least 
provisionally available. 10 However, the 
results of Gao  et al. are not suffi  cient to 
allow extrapolation of the responses into 
treatment strategies for patients with 
CKD. First, this type of dietary therapy is 
nonspecifi c, as it will change the function 
of many organs, so methods of specifi cally 
testing how changes in KLF15 infl uence 
changes in kidney function are needed. In 
addition, clinically available methods of 
determining whether other types of 
kidney diseases are associated with low 
levels of KLF15 in the kidneys of experi-
mental animals and humans will be 
required. Aft er these requirements are 
satisfied, a long-term analysis of the 
impact of raising KLF15 on other organs 
and kidney functions would be needed. 
For these reasons, these novel and tempt-
ing results must be considered prelimi-
nary with regard to influencing the 
treatment of CKD patients. 
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 Figure 1  |  Hypothetical model of KLF15 and 
the beneficial effects of low-protein diets on 
fibrosis in the kidney. Inflammation in chronic 
kidney disease (CKD) leads to downregulation 
of Kruppel-like factor-15 (KLF15) in the kidney, 
which increases extracellular matrix (ECM) 
production, leading to renal fibrosis. Low-
protein diets (LPDs) suppress inflammation 
and reverse the downregulation of KLF15, 
thereby reducing ECM production and 
renal fibrosis. 
